跳至主要内容
临床试验/NCT01123421
NCT01123421已完成不适用

Portable Ultrasonometer for Osteoporosis Assessment: Retrospective Fracture Risk Validation Study, Version #1

Artann Laboratories1 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
113
试验地点
1
主要终点
Determine whether BUSS testing is equivalent or superior to DXA for fracture risk assessment in postmenopausal women.

研究概览

简要总结

Study to demonstrate that the Bone UltraSonic Scanner (BUSS) can aid in detection of osteoporosis and predict prevalent osteoporotic fractures. Measurements derived from the BUSS parameters will be able to discriminate between postmenopausal women with osteoporotic fractures when compared to matched controls without history of osteoporotic fracture.

详细描述

One of several studies to develop and clinically validate a novel ultrasonographic device, BUSS, for the assessment of osteoporosis and fracture risk.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • postmenopausal women with osteoporotic fracture at spine or wrist
  • postmenopausal women no history of fracture at spine or wrist

排除标准

  • women with a history of metabolic disease
  • tibia fracture or surgery
  • BMI ≥ 35 kg/m2
  • Teriparatide use currently or within the past 6 months,
  • Any skin issues (open wounds or rashes, and/or skin infections) of the tibial area.

结局指标

主要结局

Determine whether BUSS testing is equivalent or superior to DXA for fracture risk assessment in postmenopausal women.

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Artann Laboratories
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验